Primary Care Clinics in Centralia, MO Accepting Medicare
5 Primary Care Clinics found. Showing 1 - 5
 Centralia Family Health Clinic Clinic/Center - Primary Care Medicare: Not Enrolled in Medicare Practice Location: 1021 E Highway 22, Centralia, MO 65240 Phone: 573-682-5580 Fax: 573-682-1539 |
Centralia Family Health, Pc Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1021 E Highway 22, Centralia, MO 65240 Phone: 573-682-5588 Fax: 573-682-1539 |
William W. Bradley, M.d., P.c. General Practice Medicare: Not Enrolled in Medicare Practice Location: 120 N Rollins St, Centralia, MO 65240 Phone: 573-682-2101 Fax: 573-682-2496 |
Boone Physician Services, Llc Clinic/Center - Rural Health Medicare: Medicare Enrolled Practice Location: 1021 E Highway 22, Centralia, MO 65240 Phone: 573-682-5588 Fax: 573-682-1539 |
Centralia Medical Clinic General Practice Medicare: Not Enrolled in Medicare Practice Location: 110 W Sneed St, Centralia, MO 65240 Phone: 573-682-1330 Fax: 573-682-1936 |
News Archive
FDA approves two SCS leads for use with Boston Scientific's Precision Plus Spinal Cord Stimulator System
Boston Scientific Corporation today announced U.S. Food and Drug Administration approval of two spinal cord stimulation (SCS) leads for use with its Precision Plus™ Spinal Cord Stimulator System, the world's first rechargeable SCS device for the management of chronic pain of the trunk and/or limbs. The Linear™ 3-4 and Linear™ 3-6 Percutaneous Leads offer wider contact spacing to expand the lead choices available to physicians. The Company plans to launch the products immediately in the U.S.; they were launched in Europe and other international markets earlier.
Health reform fact checks fall short on dispelling angry myths
A fact check of a dozen often-repeated claims by politicos and interest groups finds that the truth appears "to be taking a vacation," CQ Politics reports. Of the 12 claims, CQ concludes that only one is true, six are misleading and five are downright false.
FISH assay identifies only few lung cancer patients who could benefit from crizotinib
Break apart a couple worm-like chromosomes and they may reconnect with mismatched tips and tails - such is the case of the EML4-ALK fusion gene that creates 2-7 percent of lung cancers. Almost exactly a year ago, the FDA approved the drug crizotinib to treat these ALK+ lung cancer patients, who were likely never smokers. Informed doctors use the test called a FISH assay to check for the EML4-ALK fusion gene, and then if the test is positive, ALK+ patients benefit greatly from crizotinib.
Covestro's Makrolon polycarbonate offers many advantages for corrective lenses
Polycarbonate is the ideal lens material for corrective eyeglasses and sunglasses due to its light weight, impact resistance, durability and comfort. However, not all polycarbonate for eyewear applications is created equal.
› Verified 8 days ago